These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16160482)

  • 21. Immunohistologic pattern of the portal T-lymphocyte infiltration in hepatic allograft rejection.
    Perkins JD; Rakela J; Sterioff S; Banks PM; Wiesner RH; Krom RA
    Mayo Clin Proc; 1989 May; 64(5):565-9. PubMed ID: 2657237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathological analysis of liver allograft biopsies with late centrilobular necrosis: a comparative study in 54 patients.
    Nakazawa Y; Walker NI; Kerlin P; Steadman C; Lynch SV; Strong RW; Clouston AD
    Transplantation; 2000 Apr; 69(8):1599-608. PubMed ID: 10836369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantation.
    Stravitz RT; Shiffman ML; Sanyal AJ; Luketic VA; Sterling RK; Heuman DM; Ashworth A; Mills AS; Contos M; Cotterell AH; Maluf D; Posner MP; Fisher RA
    Liver Transpl; 2004 Jul; 10(7):850-8. PubMed ID: 15237368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Portal capillary destruction in liver allograft rejection.
    Matsumoto Y; McCaughan GW; Bishop GA
    Transplant Proc; 1992 Feb; 24(1):196-7. PubMed ID: 1539242
    [No Abstract]   [Full Text] [Related]  

  • 25. Fibrosing cholestatic hepatitis after successful interferon and ribavirin therapy for recurrent hepatitis C post living related liver transplantation: a case report.
    Yamamoto T; Tanaka S; Uenishi T; Kanazawa A; Kubo S; Hirohashi K
    Osaka City Med J; 2014 Dec; 60(2):95-100. PubMed ID: 25803885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue quantification of hepatitis C virus RNA with morphologic correlation in the diagnosis of recurrent hepatitis C virus in human liver transplants.
    Aardema KL; Nakhleh RE; Terry LK; Burd EM; Ma CK; Moonka DK; Brown KA; Abouljoud MS
    Mod Pathol; 1999 Nov; 12(11):1043-9. PubMed ID: 10574601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis C-induced hepatic allograft injury is associated with a pretransplantation elevated viral replication rate.
    Pelletier SJ; Raymond DP; Crabtree TD; Berg CL; Iezzoni JC; Hahn YS; Sawyer RG; Pruett TL
    Hepatology; 2000 Aug; 32(2):418-26. PubMed ID: 10915752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of liver allograft fibrosis after transplantation for hepatitis C virus: persistent elevation of serum transaminase levels versus necroinflammatory activity.
    Pelletier SJ; Iezzoni JC; Crabtree TD; Hahn YS; Sawyer RG; Pruett TL
    Liver Transpl; 2000 Jan; 6(1):44-53. PubMed ID: 10648577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delayed onset of severe hepatitis C-related liver damage following liver transplantation: a matter of concern?
    Berenguer M; Aguilera V; Prieto M; Carrasco D; Rayón M; San Juan F; Landaverde C; Mir J; Berenguer J
    Liver Transpl; 2003 Nov; 9(11):1152-8. PubMed ID: 14586875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Morphologic features of hepatitis C recurrence in patients after orthotopic liver transplantation-preliminary analysis of our case observations.
    Ziarkiewicz-Wróblewska B; Górnicka B; Ołdakowska-Jedynak U; Bogdańska M; Wróblewski T; Morton M; Ziółkowski J; Paczek L; Krawczyk M; Wasiutyński A
    Transplant Proc; 2006; 38(1):226-30. PubMed ID: 16504709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prevalence and natural history of untreated isolated central perivenulitis in adult allograft livers.
    Krasinskas AM; Demetris AJ; Poterucha JJ; Abraham SC
    Liver Transpl; 2008 May; 14(5):625-32. PubMed ID: 18433038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative analysis of portal tract infiltrate allows for accurate determination of hepatic allograft rejection.
    Sankary H; Foster P; Novich K; Ashmann M; Bhattacharyya A; Coleman J; Williams J
    Am J Surg; 1991 Jan; 161(1):131-4; discussion 134-5. PubMed ID: 1987847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Seeking beyond rejection: an update on the differential diagnosis and a practical approach to liver allograft biopsy interpretation.
    Gao ZH
    Adv Anat Pathol; 2009 Mar; 16(2):97-117. PubMed ID: 19550371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative evaluation of histological features in "time-zero" liver allograft biopsies as predictors of rejection or graft failure: receiver-operating characteristic analysis application.
    Abraham S; Furth EE
    Hum Pathol; 1996 Oct; 27(10):1077-84. PubMed ID: 8892594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The high prevalence of severe early posttransplant renal allograft pathology in hepatitis C positive recipients.
    Cosio FG; Sedmak DD; Henry ML; Al Haddad C; Falkenhain ME; Elkhammas EA; Davies EA; Bumgardner GL; Ferguson RM
    Transplantation; 1996 Oct; 62(8):1054-9. PubMed ID: 8900300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of liver allograft biopsy in patient management.
    Williams JW; Foster PF; Sankary HN
    Semin Liver Dis; 1992 Feb; 12(1):60-72. PubMed ID: 1570552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histological Spectrum of Idiopathic Noncirrhotic Portal Hypertension in Liver Biopsies From Dialysis Patients.
    Lee H; Ainechi S; Singh M; Ells PF; Sheehan CE; Lin J
    Int J Surg Pathol; 2015 Sep; 23(6):439-46. PubMed ID: 25882443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver transplantation for severe intrahepatic noncirrhotic portal hypertension.
    Krasinskas AM; Eghtesad B; Kamath PS; Demetris AJ; Abraham SC
    Liver Transpl; 2005 Jun; 11(6):627-34; discussion 610-1. PubMed ID: 15915493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mast cell hyperplasia in chronic rejection after liver transplantation.
    O'Keeffe C; Baird AW; Nolan N; McCormick PA
    Liver Transpl; 2002 Jan; 8(1):50-7. PubMed ID: 11799486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of cytomegalovirus viraemia on the outcome of recurrent hepatitis C after liver transplantation.
    Teixeira R; Pastacaldi S; Davies S; Dhillon AP; Emery VC; Rolles K; Davidson B; Patch D; Burroughs AK
    Transplantation; 2000 Nov; 70(10):1454-8. PubMed ID: 11118089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.